Palbobuzz 125mg Tablet

Description Palbobuzz 125mg Tablet:

Overview: Palbobuzz 125mg Tablet

Palbobuzz 125 Tablet contains Palbociclib, a targeted cancer medicine belonging to a class of drugs called CDK 4/6 inhibitors (cyclin-dependent kinase 4 and 6 inhibitors). It is prescribed to treat HR-positive (hormone receptor-positive), HER2-negative (human epidermal growth factor receptor 2-negative) advanced or metastatic breast cancer in adult patients.

Palbobuzz 125 Tablet is the highest available strength and is typically prescribed for patients who have been determined by their doctor to require this dose based on their body weight, organ function, and disease status.

The medicine works by blocking two enzymes – CDK 4 and CDK 6 – which are responsible for helping cancer cells divide and multiply. In HR-positive, HER2-negative breast cancer, these enzymes are overactive, causing uncontrolled cancer cell growth. By blocking them, Palbobuzz 125 Tablet slows down or stops the division of cancer cells, thereby controlling the progression of the disease.

Palbobuzz 125 Tablet is usually given in combination with:

• Letrozole (for postmenopausal women as initial endocrine-based therapy)
• Fulvestrant (for women with disease progression after endocrine therapy)

The medicine comes in a 21-capsule bottle for a 3-week course. The standard dosing schedule is:

• Take 1 capsule (125mg) daily for 21 consecutive days
• Then 7 days off treatment (no capsules)
• This completes one 28-day treatment cycle

Your doctor may repeat this cycle for as long as you benefit from the treatment and do not have unacceptable side effects.

Important Instructions:

• Take Palbobuzz 125mg Tablet with food (preferably a meal) to help reduce the risk of low white blood cell counts and other side effects.
• Swallow the capsule whole – do not crush, chew, dissolve, or open it.
• If you miss a dose, take it as soon as you remember if it is within 12 hours of the missed dose.
• If more than 12 hours have passed, skip the missed dose and take the next dose at the regular time.
• Do not take two doses at once to make up for a missed dose.
• If you vomit after taking a dose, do not take an extra dose – wait for the next scheduled dose.

Palbobuzz 125 Tablet slows down the growth of breast cancer cells and can help shrink tumors. It improves progression-free survival (the time during and after treatment when the cancer does not grow). However, it is not a cure for breast cancer, and it should be taken exactly as prescribed by your oncologist.

Palbobuzz 125mg Tablet – Medicinal Benefits

Palbobuzz 125 Tablet (Palbociclib) works through a unique mechanism of action:

1. CDK 4/6 Inhibition:

• Cyclin-dependent kinases 4 and 6 are enzymes that drive cell division, specifically in the G1 to S phase of the cell cycle.
• In HR-positive, HER2-negative breast cancer cells, the CDK 4/6 pathway is often overactive.
• Palbobuzz 125 Tablet blocks these enzymes, preventing the cancer cells from progressing through the cell cycle and dividing.

2. Hormonal Synergy:

• When combined with endocrine therapies (like Letrozole or Fulvestrant), Palbobuzz 125 Tablet creates a synergistic effect.
• Endocrine therapy blocks hormone signals, while Palbobuzz 125 Tablet blocks the cell division machinery.
• Together, they provide a more powerful anti-cancer effect than either drug alone.
• 3. Clinical Benefits Proven in Trials:
• PALOMA-1 Trial: Showed that Palbobuzz 125 Tablet plus Letrozole doubled progression-free survival compared to Letrozole alone (20.2 months vs. 10.2 months).
• PALOMA-2 Trial: Confirmed these results in a larger patient population (24.8 months vs. 14.5 months).
• PALOMA-3 Trial: Showed that Palbobuzz 125 Tablet plus Fulvestrant improved progression-free survival in patients who had progressed on prior endocrine therapy (9.5 months vs. 4.6 months).

4. Tumor Shrinkage:

• Approximately 55-60% of patients receiving Palbobuzz 125 Tablet plus Letrozole experienced tumor shrinkage (objective response rate).
• The benefit was seen across all patient subgroups, including those with visceral metastases.

5. Improved Quality of Life:

• By controlling the cancer, Palbobuzz 125 Tablet helps reduce cancer-related symptoms such as pain, fatigue, and weight loss.
• Patients on Palbobuzz 125 Tablet reported better physical functioning and less disease-related symptoms compared to those on endocrine therapy alone.
• 6. Oral Administration:
• Unlike intravenous chemotherapy, Palbobuzz 125 Tablet is taken orally at home, improving convenience and quality of life.

Palbobuzz 125 Tablet – Storage

Proper storage of Palbobuzz 125 Tablet is important to maintain their effectiveness:

• Store at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the capsules in their original bottle with the desiccant canister inside.
• Do not remove the desiccant canister – it helps protect the medicine from moisture.
• Keep the bottle tightly closed when not in use.
• Store away from direct sunlight, heat, and moisture.
• Do not store in the bathroom or near the kitchen sink.
• Keep out of reach of children and pets.
• Do not use the medication if the packaging is torn or shows signs of tampering.
• Do not transfer the capsules to another container (like a pill box) for long-term storage.
• If you need to carry a few capsules for travel, keep them in the original bottle or a properly labeled container.
• Check the expiration date on the bottle. Do not use after that date.
• Do not flush unused capsules down the toilet. Ask your pharmacist how to dispose of medicines you no longer use.

Palbobuzz 125mg Tablet – Drug Interactions

Palbobuzz 125 Tablet may interact with other medications and substances. It is important to inform your doctor about all medications you are currently taking, including:

• Prescription drugs
• Over-the-counter medicines
• Herbal supplements
• Vitamins and minerals
• Traditional or Ayurvedic medicines
• Why drug interactions matter with Palbobuzz 125 Tablet:
  Palbobuzz 125 Tablet is metabolized in the liver primarily by an enzyme called CYP3A4. Any drug that affects this enzyme can either increase or decrease Palbobuzz 125 Tablet levels in your blood:
• Increased Palbobuzz 125 Tablet levels → higher risk of severe side effects (especially low white blood cell counts, infections)
• Decreased Palbobuzz 125 Tablet levels → reduced effectiveness against cancer

Palbobuzz 125mg Tablet – Drug Interactions Checker List

1. Strong CYP3A4 Inhibitors (Increase Palbobuzz 125mg Tablet levels – AVOID or dose reduce):

• Ketoconazole, Itraconazole (antifungals)
• Clarithromycin, Erythromycin (antibiotics)
• Ritonavir, Indinavir, Saquinavir (HIV medications)
• Grapefruit and grapefruit juice – Avoid completely
• Nefazodone (antidepressant)
• Telithromycin (antibiotic)
• Voriconazole, Posaconazole (antifungals)

If you must take a strong CYP3A4 inhibitor, your doctor may reduce your Palbobuzz 125 Tablet dose to 75mg or 100mg.

2. Strong CYP3A4 Inducers (Decrease Palbobuzz 125mg Tablet levels – AVOID):

• Rifampin, Rifabutin, Rifapentine (TB medications)
• Carbamazepine, Phenytoin, Phenobarbital (seizure medications)
• St. John’s Wort (herbal supplement for depression) – Do not take
• Modafinil (narcolepsy medication)

These drugs can reduce Palbobuzz 125 Tablet effectiveness by more than 70%. Avoid combination or consider alternatives.

3. Moderate CYP3A4 Inhibitors (Use with caution):

• Fluconazole (antifungal)
• Diltiazem, Verapamil (blood pressure / heart medications)
• Cimetidine (antacid / ulcer medication)
• Cyclosporine (immunosuppressant)
• Amiodarone (heart rhythm medication)

4. CYP3A4 Substrates with Narrow Therapeutic Index (Monitor for toxicity):

• Alfentanil, Fentanyl (pain medications)
• Sirolimus, Everolimus, Tacrolimus (immunosuppressants)
• Warfarin (blood thinner) – Monitor INR closely
• Dihydroergotamine, Ergotamine (migraine medications)

5. Other Interactions:

• Proton pump inhibitors (Omeprazole, Pantoprazole, Rabeprazole, Esomeprazole, Lansoprazole): May reduce Palbobuzz 125 Tablet absorption. Take Palbobuzz 125 Tablet with food to minimize this effect.
• H2 blockers (Ranitidine, Famotidine, Cimetidine): May also affect absorption.
• Antacids (Aluminum, Magnesium, Calcium based): Separate by at least 2 hours if possible.

6. Vaccinations:

• Avoid live vaccines (MMR, chickenpox, nasal flu vaccine, yellow fever, rotavirus) while taking Palbobuzz 125 Tablet because your immune system may be weakened.
• Inactivated vaccines (flu shot, pneumonia vaccine) are generally safe but may be less effective.

Important: Always provide your oncologist with a complete list of all medications and supplements before starting Palbobuzz 125 Tablet. Do not start any new medicine or supplement without consulting your doctor.

Palbobuzz 125mg Tablet – Safety Advice

1. Blood Cell Counts:

• Palbobuzz 125 Tablet commonly causes low white blood cell counts (neutropenia) . Your doctor will check your complete blood count (CBC):
• Before starting treatment
• At the beginning of each cycle
• On Day 15 of the first 2 cycles
• As clinically indicated
• If your absolute neutrophil count (ANC) falls below 1,000/mm³, your doctor may:
• Interrupt Palbobuzz 125 Tablet until recovery
• Reduce the dose to 100mg or 75mg
• Delay the next cycle

2. Infections:

• Due to low white blood cells, you are at higher risk of infections.
• Watch for signs of infection: fever (temperature ≥ 100.5°F / 38°C), chills, sore throat, cough, burning with urination.
• Report fever immediately – do not wait.
• Do not take “fever-reducing” medicines and ignore the fever – it could be a serious infection.

3. Bleeding / Bruising:

• Palbobuzz 125 Tablet may also cause low platelet counts (thrombocytopenia).
• Watch for unusual bruising, bleeding gums, blood in urine or stool, or prolonged bleeding from cuts.
• Report any unusual bleeding to your doctor.

4. Liver Function:

• Palbobuzz 125 Tablet can cause elevated liver enzymes.
• Your doctor will check liver function tests before starting and regularly during treatment.
• Inform your doctor if you experience: yellowing of skin/eyes (jaundice), dark urine, severe nausea/vomiting, loss of appetite, upper right abdominal pain.

5. Pregnancy and Contraception:

• Palbobuzz 125 Tablet is UNSAFE during pregnancy. It can cause harm to the developing baby.
• Women of childbearing potential: Must use effective contraception during treatment and for at least 3 weeks after the last dose.
• Men with female partners of childbearing potential: Must use effective contraception during treatment and for at least 3 months after the last dose.
• Pregnancy testing: Should be done within 7 days before starting Palbobuzz 125 Tablet.
• Breastfeeding: Do not breastfeed during treatment and for at least 3 weeks after the last dose.

6. Fertility:

• Palbobuzz 125mg Tablet may affect fertility in both men and women.
• If you are concerned about future fertility, discuss fertility preservation options with your doctor before starting treatment.

7. Driving and Operating Machinery:

• Palbobuzz 125 Tablet may cause fatigue, dizziness, or weakness.
• Do not drive or operate heavy machinery if you experience these side effects.

8. Alcohol:

• Caution advised when consuming alcohol with Palbobuzz 125 Tablet.
• Alcohol may increase the risk of liver damage and can worsen nausea.
• Consult your doctor about alcohol use during treatment.

9. Kidney Disease:

• Palbobuzz 125 Tablet is probably safe in patients with mild to moderate kidney disease.
• For severe kidney disease (eGFR < 30 mL/min), dose adjustment may be needed.
• Your doctor will monitor kidney function through blood tests.

10. Liver Disease:

• Palbobuzz 125 Tablet is metabolized in the liver.
• For mild to moderate liver impairment (Child-Pugh A or B), no dose adjustment is needed but monitor closely.
• For severe liver impairment (Child-Pugh C), the recommended starting dose is 75mg (not 125mg).

11. Children:

• Safety and effectiveness of Palbobuzz 125 Tablet in children have not been established.
• Not recommended for use in children and adolescents under 18 years.

12. Elderly Patients (≥ 65 years):

• No overall differences in safety or effectiveness were observed between elderly and younger patients.
• However, elderly patients may be more sensitive to side effects like low blood counts and fatigue.

13. Dental Procedures:

• Inform your dentist that you are taking Palbobuzz 125 Tablet.
• Low platelet counts may increase bleeding risk during dental procedures.
• Low white blood cell counts may increase infection risk after dental work.

14. Surgery:

• Inform your surgeon that you are taking Palbobuzz 125 Tablet.
• Your doctor may advise stopping Palbobuzz 125 Tablet before and after surgery due to infection and bleeding risks.

Habit forming: NO – Palbobuzz 125 Tablet does not cause addiction or dependence.

Uses of Palbobuzz 125mg Tablet

Product Benefits

Palbobuzz 125 Tablet is used for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in adult patients.

Approved Indications:

1. First-line treatment in combination with Letrozole:
2. For postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer.
3. As initial endocrine-based therapy.
4. In combination with Fulvestrant:
5. For women with HR-positive, HER2-negative advanced or metastatic breast cancer.
6. For those who have had disease progression after endocrine therapy.
7. In pre/perimenopausal women:
8. In combination with Letrozole or Fulvestrant AND a luteinizing hormone-releasing hormone (LHRH) agonist (such as goserelin or leuprolide).

Key Benefits:

✅ Slows cancer progression – Palbobuzz 125mg Tablet significantly improves progression-free survival, meaning patients go longer without their cancer growing or spreading.

✅ Shrinks tumors – Approximately 55-60% of patients experience measurable tumor shrinkage when Palbobuzz 125 Tablet is combined with Letrozole.

✅ Delays need for chemotherapy – By effectively controlling the cancer with an oral targeted therapy, Palbobuzz 125 Tablet can delay the need for intravenous chemotherapy and its associated side effects.

✅ Improves quality of life – Patients on Palbobuzz 125 Tablet report better physical functioning and less disease-related symptoms compared to those on endocrine therapy alone.

✅ Oral convenience – Taken at home, not in a hospital or clinic.

✅ Targeted action – Palbobuzz 125 Tablet specifically targets cancer cells, with fewer severe side effects than traditional chemotherapy.

✅ Well-tolerated – Most side effects are manageable, and severe side effects are less common compared to chemotherapy.

✅ Proven in clinical trials – PALOMA-1, PALOMA-2, and PALOMA-3 trials have established Palbobuzz 125 Tablet as a standard of care for HR-positive, HER2-negative advanced breast cancer.

What Palbobuzz 125mg Tablet Does NOT Do:

• It is not a cure for breast cancer.
• It does not prevent breast cancer from coming back after initial treatment (adjuvant setting) – this is still being studied.
• It does not treat HER2-positive breast cancer or triple-negative breast cancer.
• It is not a substitute for chemotherapy in all cases.

Important: Taking all doses as prescribed, at the right time, and with food greatly increases the effectiveness of Palbobuzz 125 Tablet. Skipping doses or not completing the full 21-day on / 7-day off schedule can reduce the medicine’s ability to control your cancer and may lead to drug resistance.

Side Effects of Palbobuzz 125 Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. However, some side effects can be serious and require immediate medical attention. Consult your doctor if side effects persist or if you are worried about them.

Common side effects of Palbobuzz 125 Tablet (occurring in >10% of patients):

Very Common (may affect more than 1 in 10 people):

• Neutropenia (low white blood cell count) – This is the most common side effect, occurring in up to 80% of patients. It increases your risk of infections. Your doctor will monitor your blood counts regularly and may adjust your dose if needed.
• Fatigue / asthenia – Feeling very tired, weak, or lacking energy. This affects approximately 40-50% of patients. Rest as needed, stay hydrated, and maintain light physical activity as tolerated.
• Nausea – Affects about 35% of patients. Usually mild to moderate. Taking Palbobuzz 125 Tablet with food helps. If severe, your doctor can prescribe anti-nausea medication.
• Infections – Due to low white blood cells. Upper respiratory tract infections (common cold) are most frequent. Watch for fever, chills, sore throat, or cough.
• Decreased appetite – Affects about 30% of patients. Eat small, frequent meals. Choose nutrient-dense foods.
• Diarrhea – Affects about 25% of patients. Drink plenty of fluids. Your doctor may recommend anti-diarrheal medication if severe.
• Mouth sores (stomatitis) – Affects about 20-25% of patients. Use a soft-bristled toothbrush, avoid spicy or acidic foods, and rinse with salt water. Your doctor may prescribe a special mouthwash.
• Hair thinning or hair loss (alopecia) – Affects about 15-20% of patients. This is usually mild to moderate and reversible after stopping treatment.
• Vomiting – Affects about 15-20% of patients. Take with food to reduce vomiting. Anti-nausea medication can help.
• Rash – Affects about 15% of patients. Usually mild. Use moisturizer and avoid harsh soaps. Severe rash is rare but report it.
• Anemia (low red blood cell count) – Affects about 10-15% of patients. May cause tiredness, weakness, pale skin, or shortness of breath.
• Thrombocytopenia (low platelet count) – Affects about 10-15% of patients. May cause easy bruising or bleeding. Severe cases are uncommon.
• Dizziness – Affects about 10% of patients. Be cautious when driving or operating machinery.
• Headache – Affects about 10% of patients. Usually mild and resolves with rest or over-the-counter pain relievers (after consulting doctor).
• Constipation – Affects about 10% of patients. Drink plenty of water and eat fiber-rich foods.
• Dry skin – Affects about 10% of patients. Use moisturizer regularly.
• Taste changes (dysgeusia) – Food may taste different or metallic. Usually temporary.
• Cough – Affects about 10% of patients.
• Shortness of breath (dyspnea) – Affects about 10% of patients. Report if new or worsening.
• Nosebleeds (epistaxis) – Affects about 10% of patients. Usually mild.
• Tearing eyes (epiphora) – Affects about 10% of patients.
• Increased tear production – Affects about 10% of patients.

Less Common Side Effects (occurring in 1-10% of patients):

• Abdominal pain
• Dry mouth
• Indigestion (dyspepsia)
• Heartburn / acid reflux
• Flatulence (gas)
• Weight loss
• Muscle pain (myalgia)
• Joint pain (arthralgia)
• Back pain
• Pain in extremities
• Insomnia (trouble sleeping)
• Anxiety
• Depression
• Abnormal dreams
• Blurred vision
• Dry eyes
• Ringing in ears (tinnitus)
• Hair color changes (whitening or darkening)
• Nail changes (discoloration, brittleness)
• Hand-foot skin reaction (redness, swelling, peeling on palms and soles)
• Night sweats
• Hot flashes
• Dehydration
• Electrolyte imbalances (low sodium, low potassium)
• Increased creatinine levels (kidney function test)
• Increased liver enzymes (ALT, AST)

Serious Side Effects (Require Immediate Medical Attention):

Seek emergency medical help if you experience:

• Fever (temperature ≥ 100.5°F / 38°C) with or without chills – This could indicate a serious infection due to low white blood cells. Do not wait – contact your doctor immediately.

• Signs of severe infection: Sore throat, cough with phlegm, burning with urination, redness/swelling anywhere on body.

• Signs of bleeding: Unusual bruising, blood in urine (pink or red), blood in stool (black or tarry stools), bleeding gums, coughing up blood, vomiting blood (looks like coffee grounds).

• Signs of liver damage: Yellowing of skin or eyes (jaundice), dark brown urine, severe nausea/vomiting, loss of appetite, pain in upper right abdomen.

• Signs of severe lung inflammation (pneumonitis): New or worsening cough, shortness of breath, chest pain, difficulty breathing, wheezing.

• Signs of severe allergic reaction: Rash all over body, hives, itching, swelling of face/lips/tongue/throat, difficulty swallowing or breathing, dizziness or fainting.

• Signs of heart problems: Chest pain, irregular heartbeat, severe dizziness, fainting.

• Signs of blood clots: Pain, swelling, warmth, or redness in one leg; sudden shortness of breath; sharp chest pain; coughing up blood.

Note: This is not a complete list of all possible side effects. Tell your doctor about any side effect that bothers you or does not go away.

How to Take Palbobuzz 125mg Tablet

Take this medicine exactly as prescribed by your doctor. Do not change the dose or stop taking Palbobuzz 125 Tablet without consulting your doctor first.

Standard Dosing Schedule:

• 21 days ON: Take 1 capsule (125mg) once daily for 21 consecutive days

• 7 days OFF: Do not take any Palbobuzz 125 Tablet capsules for 7 days

• This completes one 28-day treatment cycle

• Your doctor will repeat cycles as long as you are benefiting from treatment

Instructions for Taking:

• Take Palbobuzz 125 Tablet with food (a meal is preferred, but a snack is acceptable). Taking with food helps reduce nausea and the risk of low white blood cell counts.

• Swallow the capsule whole. Do not crush, chew, break, or open the capsule.

• If the capsule is damaged or opened, avoid direct contact with the contents. Wash hands thoroughly if contact occurs.

• Take Palbobuzz 125 Tablet at approximately the same time each day to maintain consistent blood levels.

• Swallow with a glass of water.

What to do if you miss a dose:

• If you miss a dose and less than 12 hours have passed: Take the missed dose as soon as you remember.

• If you miss a dose and more than 12 hours have passed: Skip the missed dose. Take your next dose at the regular scheduled time.

• Do not take two doses at once to make up for a missed dose.

• If you vomit after taking a dose: Do not take an extra dose. Wait for your next scheduled dose.

What to do if you take too much (overdose):

• Seek emergency medical attention immediately or call your local poison control center.

• Overdose may cause severe low blood counts, severe infections, or bleeding.

Monitoring During Treatment:
Your doctor will perform regular blood tests:

• Complete Blood Count (CBC): Before each cycle, and on Day 15 of the first 2 cycles

• Liver function tests: Periodically during treatment

• Kidney function tests: Periodically during treatment

• Pregnancy test: Before starting treatment (for women of childbearing potential)

Dose Adjustments:
Your doctor may temporarily interrupt treatment, delay the next cycle, or reduce your dose if you experience:

• Severe low white blood cell counts (neutropenia)

• Low platelet counts (thrombocytopenia)

• Other significant side effects

Standard dose reductions:

• First dose reduction: 100mg (once daily, 21 days on / 7 days off)

• Second dose reduction: 75mg (once daily, 21 days on / 7 days off)

How Palbobuzz 125mg Tablet Works

Palbobuzz 125 Tablet (Palbociclib) is a selective CDK 4/6 inhibitor that works by blocking two enzymes critical for cell division.

The Science Behind CDK 4/6:

Cells in the body divide and multiply through a process called the cell cycle. The cell cycle has different phases:

• G1 phase: Cell grows and prepares for DNA replication

• S phase: DNA is synthesized (copied)

• G2 phase: Cell prepares for division

• M phase: Mitosis (cell divides)

To move from the G1 phase to the S phase, cells need to activate two enzymes called:

• Cyclin-dependent kinase 4 (CDK 4)

• Cyclin-dependent kinase 6 (CDK 6)

These enzymes act like “gas pedals” that push the cell through the cell cycle.

What happens in HR-positive, HER2-negative breast cancer:

In these cancers, the CDK 4/6 pathway is overactive. The cancer cells divide rapidly and uncontrollably because the “gas pedal” is stuck down. The cancer cells are also driven by hormone signals (estrogen) that further activate CDK 4/6.

How Palbobuzz 125mg Tablet works:

Palbobuzz 125 Tablet binds to CDK 4 and CDK 6 and blocks their activity. This effectively “presses the brake” on the cell cycle. The cancer cells cannot move from G1 phase to S phase, so they cannot divide. The cancer cells may also undergo senescence (they stop dividing permanently) or apoptosis (cell death).

Synergy with Hormonal Therapy:

When Palbobuzz 125 Tablet is combined with Letrozole or Fulvestrant (hormonal therapies), the two drugs work together:

• Letrozole/Fulvestrant blocks estrogen signaling that drives cancer growth

• Palbobuzz 125 Tablet blocks the cell division machinery that cancer cells need to multiply

This combination is much more effective than either drug alone.

Effect on Normal Cells:

CDK 4/6 are also important for normal cell division, especially in:

• Bone marrow cells (which produce white blood cells, red blood cells, and platelets) – This explains why low blood counts are a common side effect.

• Hair follicles – Explains hair thinning.

• Mouth lining cells – Explains mouth sores.

However, Palbobuzz 125 Tablet is selective for CDK 4/6 and has fewer effects on other parts of the body compared to traditional chemotherapy.

Results in the Body:

• Cancer cells stop dividing

• Tumor growth slows down or stops (disease stabilization)

• Tumors may shrink (partial or complete response)

• Patients have longer progression-free survival (more time before the cancer grows or spreads)

• Cancer-related symptoms improve

Resistance to Palbobuzz 125mg Tablet:

Over time, some cancers may become resistant to Palbobuzz 125 Tablet. This can happen through several mechanisms:

• Mutations in the CDK 4/6 pathway

• Activation of alternative cell cycle pathways

• Other genetic changes in the cancer

If resistance develops, your oncologist may recommend other treatments, such as switching to a different CDK 4/6 inhibitor (Ribociclib, Abemaciclib) or moving to chemotherapy.

Palbobuzz 125mg Tablet – Storage

• Store at room temperature between 20°C to 25°C (68°F to 77°F).

• Keep in the original bottle with the desiccant canister.

• Do not remove the desiccant canister.

• Keep the bottle tightly closed.

• Store away from light, heat, and moisture.

• Do not store in the bathroom.

• Keep out of reach of children and pets.

• Do not use after the expiration date on the bottle.

• Do not flush down the toilet. Ask your pharmacist how to dispose of unused medicine.

Frequently Asked Questions (FAQs) About Palbobuzz 125mg Tablet Capsule

Q1: What is Palbobuzz 125mg Tablet used for?

A: Palbobuzz 125 Tablet is used to treat HR-positive, HER2-negative advanced or metastatic breast cancer in combination with Letrozole or Fulvestrant.

Q2: What is the price of Palbobuzz 125mg Tablet in India?

A: The price ranges from ₹2,299 to ₹6,750 per bottle of 21 capsules, depending on quantity. The best rate is available at ₹2,299 with free shipping and cod available from hivhub.in

Q3: How long do I need to take Palbobuzz 125mg Tablet?

A: As long as it remains effective and side effects are manageable. Your oncologist will monitor with regular scans. Treatment cycles are 28 days each (21 days on, 7 days off).

Q4: Can I take Palbobuzz 125mg Tablet with food?

A: Yes, you should take Palbobuzz 125 Tablet with food (preferably a meal) to reduce nausea and the risk of low white blood cell counts.

Q5: Does Palbobuzz 125 Tablet cause hair loss?

A: Hair thinning or mild hair loss may occur in about 15-20% of patients, but complete baldness is less common compared to chemotherapy. Hair usually grows back after stopping treatment.

Q6: Can I drink grapefruit juice while taking Palbobuzz 125mg Tablet?

A: No. Grapefruit and grapefruit juice increase Palbobuzz 125 Tablet levels in your blood, raising the risk of severe side effects. Avoid completely.

Q7: Does Palbobuzz 125mg Tablet affect blood counts?

A: Yes. Palbobuzz 125 Tablet commonly causes low white blood cell counts (neutropenia), low red blood cell counts (anemia), and low platelet counts (thrombocytopenia). Your doctor will monitor your blood counts regularly.

Q8: Can Palbobuzz 125 Tablet be taken with other breast cancer medicines?

A: Yes. Palbobuzz 125 Tablet is specifically designed to be taken with Letrozole (first-line) or Fulvestrant (after progression). Do not take any other medicines without consulting your doctor.

Q9: What should I do if I have a fever while taking Palbobuzz 125 Tablet?

A: Contact your doctor immediately. Fever could indicate a serious infection due to low white blood cells. Do not wait.

Q10: Is Palbobuzz 125mg Tablet a chemotherapy drug?

A: No. Palbobuzz 125 Tablet is a targeted therapy (CDK 4/6 inhibitor), not traditional chemotherapy. It works differently and generally has fewer severe side effects.

Q11: Does Palbobuzz 125 Tablet cause fatigue?

A: Yes, fatigue is very common (affects 40-50% of patients). Rest as needed but try to stay lightly active. Fatigue usually improves after the first few cycles.

Q12: Can I take antacids with Palbobuzz 125mg Tablet?

A: Yes, but separate by at least 2 hours if possible. Antacids containing aluminum, magnesium, or calcium may reduce Palbobuzz 125 Tablet absorption.

Q13: What happens if I miss a dose of Palbobuzz 125mg Tablet?

A: If less than 12 hours have passed, take it. If more than 12 hours have passed, skip it and take the next dose at the regular time. Do not double the dose.

Q14: Does Palbobuzz 125mg Tablet cause weight gain or weight loss?

A: Weight loss is more common due to decreased appetite. Weight gain is less common. Maintain a healthy diet and eat small, frequent meals.

Q15: Can I take Palbobuzz 125 Tablet with blood pressure medicines?

A: Some blood pressure medications like diltiazem and verapamil can interact with Palbobuzz 125 Tablet. Tell your doctor about all your medicines.

Q16: Is it safe to take paracetamol with Palbobuzz 125mg Tablet?

A: Yes, paracetamol (acetaminophen) is generally safe. Avoid NSAIDs like ibuprofen unless your doctor approves, as they may increase bleeding risk if platelet counts are low.

Q17: Does Palbobuzz 125mg Tablet affect the liver?

A: Palbobuzz 125 Tablet can cause elevated liver enzymes. Your doctor will monitor your liver function through blood tests. Report jaundice, dark urine, or severe nausea.

Q18: Can I take Palbobuzz 125mg Tablet if I have kidney disease?

A: Palbobuzz 125 Tablet is probably safe in mild to moderate kidney disease. For severe kidney disease (eGFR < 30 mL/min), dose adjustment may be needed.

Q19: How should I store Palbobuzz 125 Tablet?

A: Store at room temperature (20-25°C) in the original bottle with the desiccant canister. Keep tightly closed, away from heat, light, and moisture.

Q20: Can I crush or open Palbobuzz 125 Tablet ?

A: No. Swallow the capsule whole. Do not crush, chew, break, or open it. If a capsule is damaged, avoid direct contact with the contents.

Q21: Does Palbobuzz 125 Tablet cause mouth sores?

A: Yes, mouth sores (stomatitis) occur in about 20-25% of patients. Use a soft toothbrush, avoid spicy/acidic foods, and rinse with salt water.

Q22: Can I take Palbobuzz 125mg Tablet during an infection or fever?

A: Inform your doctor immediately if you have an infection or fever. Do not stop Palbobuzz 125 Tablet without medical advice, but your doctor may temporarily interrupt treatment.

Q23: Does Palbobuzz 125mg Tablet cause hand-foot skin reaction?

A: Yes, in about 10% of patients. Redness, swelling, or peeling on palms and soles may occur. Moisturize regularly and wear comfortable shoes.

Q24: Can I take vitamin supplements with Palbobuzz 125 Tablet?

A: Yes, but avoid herbal supplements like St. John’s Wort. Inform your doctor about all supplements, especially those that affect liver enzymes.

Q25: When should I call my doctor immediately?

A: If you have fever (≥100.5°F / 38°C), signs of infection, unusual bleeding or bruising, yellowing of skin/eyes, severe nausea/vomiting, chest pain, shortness of breath, or sudden swelling of hands/feet.

Q26: Is Palbobuzz 125mg Tablet covered by insurance in India?

A: Many health insurance plans cover Palbobuzz 125 Tablet for approved indications. Check with your insurance provider. Some patient assistance programs may also be available.

Q27: Can I drink alcohol while taking Palbobuzz 125 Tablet?

A: Caution advised. Alcohol may increase liver strain and worsen nausea. Consult your doctor.

Q28: Does Palbobuzz 125mg Tablet cause constipation or diarrhea?

A: Both can occur. Diarrhea affects about 25% of patients, constipation about 10%. Stay hydrated and inform your doctor if severe.

Q29: Can I exercise while taking Palbobuzz 125 Tablet?

A: Yes, light to moderate exercise is encouraged. Listen to your body and rest when fatigued. Avoid contact sports if platelet counts are low.

Q30: How long does it take for Palbobuzz 125mg Tablet to start working?

A: Some patients feel better within weeks, but cancer response is typically assessed after 2-3 cycles (2-3 months) with imaging scans (CT, MRI, PET).

Q31: Does Palbobuzz 125 Tablet cause lung problems?

A: Rarely, Palbobuzz 125 Tablet can cause interstitial lung disease (ILD) or pneumonitis (inflammation of the lungs). Report new or worsening cough, shortness of breath, or chest pain immediately.

Q32: Can I travel while taking Palbobuzz 125 Tablet?

A: Yes, but carry your medicine in its original bottle with the prescription. Inform your doctor before long trips. Ensure you have enough medicine for the duration.

Q33: Does Palbobuzz 125mg Tablet affect birth control?

A: Palbobuzz 125 Tablet does not make hormonal birth control less effective, but you must use effective contraception during treatment and for at least 3 weeks (women) or 3 months (men) after the last dose.

Q34: Can men take Palbobuzz 125 Tablet?

A: Yes, Palbobuzz 125 Tablet is approved for both men and women with HR-positive, HER2-negative advanced breast cancer. Men may also need an LHRH agonist.

Q35: Is there a generic version of Palbobuzz 125mg Tablet available in India?

A: Yes, generic Palbociclib is available at lower cost. Branded Palbobuzz 125 Tablet (JASGUR LIFE SCIENCES LLP) is also available. Discuss with your doctor.

Q36: Does Palbobuzz 125 Tablet cause night sweats?

A: Night sweats affect about 10% of patients. This is usually not serious but can be uncomfortable.

Q37: Can I take Palbobuzz 125mg Tablet with proton pump inhibitors (PPIs) like omeprazole?

A: Yes, but separation is not required. However, taking Palbobuzz 125 Tablet with food helps ensure adequate absorption even if you take PPIs.

Q38: What is the difference between Palbobuzz 125mg Tablet , 100mg, and 75mg?

A: Different strengths for dose adjustments. 125mg is the standard starting dose. Your doctor will reduce to 100mg or 75mg if you experience severe side effects.

Q39: Can I stop Palbobuzz 125mg Tablet if my cancer goes into remission?

A: Do not stop without consulting your doctor. Even if scans show no detectable cancer, stopping Palbobuzz 125 Tablet may allow the cancer to return.

Q40: Does Palbobuzz 125mg Tablet cause tooth problems?

A: Palbobuzz 125 Tablet does not directly damage teeth, but low white blood cell counts increase risk of oral infections. Maintain good oral hygiene and see your dentist regularly.

References / Sources:

1. FDA Prescribing Information – Ibrance (Palbociclib)
   🔗 https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/207103s024lbl.pdf

2. Pfizer Medical Information – Ibrance
   🔗 https://www.pfizermedicalinformation.com/en-us/ibrance

3. MedlinePlus – Palbociclib
   🔗 https://medlineplus.gov/druginfo/meds/a615007.html

4. National Comprehensive Cancer Network (NCCN) – Breast Cancer Guidelines
   🔗 https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419

5. American Cancer Society – Targeted Therapy for Breast Cancer
   🔗 https://www.cancer.org/cancer/breast-cancer/treatment/targeted-therapy-for-breast-cancer.html

6. PALOMA-1 Clinical Trial (Finn et al., The Lancet Oncology, 2015)
   🔗 https://pubmed.ncbi.nlm.nih.gov/25692914/

7. PALOMA-2 Clinical Trial (Finn et al., The New England Journal of Medicine, 2016)
   🔗 https://pubmed.ncbi.nlm.nih.gov/27959759/

8. PALOMA-3 Clinical Trial (Cristofanilli et al., The New England Journal of Medicine, 2016)
   🔗 https://pubmed.ncbi.nlm.nih.gov/26773088/

9. Drugs.com – Palbociclib
   🔗 https://www.drugs.com/palbociclib.html

10. European Medicines Agency (EMA) – Ibrance
    🔗 https://www.ema.europa.eu/en/medicines/human/EPAR/ibrance

11. WebMD – Ibrance Oral
    🔗 https://www.webmd.com/drugs/2/drug-169480/ibrance-oral/details

12. Breastcancer.org – CDK 4/6 Inhibitors
    🔗 https://www.breastcancer.org/treatment/targeted-therapy/cdk-46-inhibitors

Disclaimer

CancerHub’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on CancerHub. Our mission is to support, not replace, the doctor-patient relationship.

Important Note: Palbobuzz 125mg Tablet (Palbociclib) is a prescription-only medicine. Do not take this medicine without a prescription from a qualified oncologist. The information provided here is based on published medical literature and FDA/EMA prescribing information. Individual patient experiences may vary. Always consult your doctor before starting, stopping, or changing any cancer treatment.

Substitutes for Palbobuzz 125mg Tablet